{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:22:42Z","timestamp":1773832962160,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,18]]},"DOI":"10.7759\/cureus.62597","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T12:08:26Z","timestamp":1718712506000},"source":"Crossref","is-referenced-by-count":1,"title":["Acute Kidney Injury Due to Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease Treated With Tolvaptan: A Case Report"],"prefix":"10.7759","author":[{"given":"Hisato","family":"Shima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Nishitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Izaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Minakuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/2054358117695784","article-title":"Assessing risk of disease progression and pharmacological management of autosomal dominant polycystic kidney disease: a Canadian expert consensus","volume":"4","author":"Soroka S","year":"2017","unstructured":"Soroka S, Alam A, Bevilacqua M, et al.. Assessing risk of disease progression and pharmacological management of autosomal dominant polycystic kidney disease: a Canadian expert consensus. Can J Kidney Health Dis. 2017, 4:2054358117695784. 10.1177\/2054358117695784","journal-title":"Can J Kidney Health Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(88)80137-9","article-title":"The association of nephrolithiasis and autosomal dominant polycystic kidney disease","volume":"11","author":"Torres VE","year":"1988","unstructured":"Torres VE, Erickson SB, Smith LH, Wilson DM, Hattery RR, Segura JW. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1988, 11:318-25. 10.1016\/s0272-6386(88)80137-9","journal-title":"Am J Kidney Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67792-0","article-title":"Nephrolithiasis associated with autosomal dominant polycystic kidney disease: contemporary urological management","volume":"163","author":"Ng CS","year":"2000","unstructured":"Ng CS, Yost A, Streem SB. Nephrolithiasis associated with autosomal dominant polycystic kidney disease: contemporary urological management. J Urol. 2000, 163:726-9. 10.1016\/S0022-5347(05)67792-0","journal-title":"J Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-011-0090-z","article-title":"Percutaneous nephrolithotomy in polycystic kidney disease: is it safe and effective?","volume":"44","author":"Srivastava A","year":"2012","unstructured":"Srivastava A, Bansal R, Srivastava A, et al.. Percutaneous nephrolithotomy in polycystic kidney disease: is it safe and effective?. Int Urol Nephrol. 2012, 44:725-30. 10.1007\/s11255-011-0090-z","journal-title":"Int Urol Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/2054358120934628","article-title":"Stone prevalence in autosomal dominant polycystic kidney disease: a systematic review and meta-analysis","volume":"7","author":"Kalatharan V","year":"2020","unstructured":"Kalatharan V, Grewal G, Nash DM, Welk B, Sarma S, Pei Y, Garg AX. Stone prevalence in autosomal dominant polycystic kidney disease: a systematic review and meta-analysis. Can J Kidney Health Dis. 2020, 7:2054358120934628. 10.1177\/2054358120934628","journal-title":"Can J Kidney Health Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab312","article-title":"An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International","volume":"37","author":"M\u00fcller RU","year":"2022","unstructured":"M\u00fcller RU, Messchendorp AL, Birn H, et al.. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Nephrol Dial Transplant. 2022, 37:825-39. 10.1093\/ndt\/gfab312","journal-title":"Nephrol Dial Transplant"},{"key":"ref7","article-title":"Acute kidney injury: definition, pathophysiology and clinical phenotypes","volume":"37","author":"Makris K","year":"2016","unstructured":"Makris K, Spanou L. Acute kidney injury: definition, pathophysiology and clinical phenotypes. Clin Biochem Rev. 2016, 37:85-98.","journal-title":"Clin Biochem Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04029.x","article-title":"Tolvaptan","volume":"73","author":"Dubois EA","year":"2012","unstructured":"Dubois EA, Rissmann R, Cohen AF. Tolvaptan. Br J Clin Pharmacol. 2012, 73:9-11. 10.1111\/j.1365-2125.2011.04029.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018060590","article-title":"A practical guide for treatment of rapidly progressive ADPKD with tolvaptan","volume":"29","author":"Chebib FT","year":"2018","unstructured":"Chebib FT, Perrone RD, Chapman AB, et al.. A practical guide for treatment of rapidly progressive ADPKD with tolvaptan. J Am Soc Nephrol. 2018, 29:2458-70. 10.1681\/ASN.2018060590","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03100608","article-title":"Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients","volume":"4","author":"Nishiura JL","year":"2009","unstructured":"Nishiura JL, Neves RF, Eloi SR, Cintra SM, Ajzen SA, Heilberg IP. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol. 2009, 4:838-44. 10.2215\/CJN.03100608","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(12)80922-x","article-title":"Renal stone disease in autosomal dominant polycystic kidney disease","volume":"22","author":"Torres VE","year":"1993","unstructured":"Torres VE, Wilson DM, Hattery RR, Segura JW. Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1993, 22:513-9. 10.1016\/s0272-6386(12)80922-x","journal-title":"Am J Kidney Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0804458","article-title":"Clinical practice. Autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham JJ","year":"2008","unstructured":"Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med. 2008, 359:1477-85. 10.1056\/NEJMcp0804458","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-020-01882-z","article-title":"Laparoscopic ureterolithotomy, flexible ureteroscopic lithotripsy and percutaneous nephrolithotomy for treatment of upper urinary calculi in patients with autosomal dominant polycystic kidney disease","volume":"24","author":"Xu Y","year":"2020","unstructured":"Xu Y, Bai Z, Ma D, et al.. Laparoscopic ureterolithotomy, flexible ureteroscopic lithotripsy and percutaneous nephrolithotomy for treatment of upper urinary calculi in patients with autosomal dominant polycystic kidney disease. Clin Exp Nephrol. 2020, 24:842-8. 10.1007\/s10157-020-01882-z","journal-title":"Clin Exp Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-006-0059-z","article-title":"Treatment of calculi in kidneys with congenital anomalies: an assessment of the efficacy of lithotripsy","volume":"34","author":"Al-Tawheed AR","year":"2006","unstructured":"Al-Tawheed AR, Al-Awadi KA, Kehinde EO, Abdul-Halim H, Hanafi AM, Ali Y. Treatment of calculi in kidneys with congenital anomalies: an assessment of the efficacy of lithotripsy. Urol Res. 2006, 34:291-8. 10.1007\/s00240-006-0059-z","journal-title":"Urol Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1089\/end.2010.0093","article-title":"Nephrolithiasis in autosomal dominant polycystic kidney disease","volume":"24","author":"Mufti UB","year":"2010","unstructured":"Mufti UB, Nalagatla SK. Nephrolithiasis in autosomal dominant polycystic kidney disease. J Endourol. 2010, 24:1557-61. 10.1089\/end.2010.0093","journal-title":"J Endourol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.07.041","article-title":"EAU guidelines on interventional treatment for urolithiasis","volume":"69","author":"T\u00fcrk C","year":"2016","unstructured":"T\u00fcrk C, Pet\u0159\u00edk A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T. EAU guidelines on interventional treatment for urolithiasis. Eur Urol. 2016, 69:475-82. 10.1016\/j.eururo.2015.07.041","journal-title":"Eur Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2001.00781.x","article-title":"Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal calyceal stones","volume":"87","author":"Keeley FX Jr","year":"2001","unstructured":"Keeley FX Jr, Tilling K, Elves A, Menezes P, Wills M, Rao N, Feneley R. Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal calyceal stones. BJU Int. 2001, 87:1-8. 10.1046\/j.1464-410x.2001.00781.x","journal-title":"BJU Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.178.1.1780101","article-title":"Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT","volume":"178","author":"Coll DM","year":"2002","unstructured":"Coll DM, Varanelli MJ, Smith RC. Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol. 2002, 178:101-3. 10.2214\/ajr.178.1.1780101","journal-title":"AJR Am J Roentgenol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14565","article-title":"Outcomes of long-term follow-up of asymptomatic renal stones and prediction of stone-related events","volume":"123","author":"Li X","year":"2019","unstructured":"Li X, Zhu W, Lam W, Yue Y, Duan H, Zeng G. Outcomes of long-term follow-up of asymptomatic renal stones and prediction of stone-related events. BJU Int. 2019, 123:485-92. 10.1111\/bju.14565","journal-title":"BJU Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/254783-acute-kidney-injury-due-to-nephrolithiasis-in-autosomal-dominant-polycystic-kidney-disease-treated-with-tolvaptan-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T12:08:30Z","timestamp":1718712510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/254783-acute-kidney-injury-due-to-nephrolithiasis-in-autosomal-dominant-polycystic-kidney-disease-treated-with-tolvaptan-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.62597","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,18]]}}}